Sun Pharmaceutical Industries Balance Sheet Health
Financial Health criteria checks 6/6
Sun Pharmaceutical Industries has a total shareholder equity of ₹632.0B and total debt of ₹19.3B, which brings its debt-to-equity ratio to 3.1%. Its total assets and total liabilities are ₹794.4B and ₹162.4B respectively. Sun Pharmaceutical Industries's EBIT is ₹102.1B making its interest coverage ratio -37.3. It has cash and short-term investments of ₹148.3B.
Key information
3.1%
Debt to equity ratio
₹19.28b
Debt
Interest coverage ratio | -37.3x |
Cash | ₹148.33b |
Equity | ₹631.97b |
Total liabilities | ₹162.44b |
Total assets | ₹794.41b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524715's short term assets (₹393.5B) exceed its short term liabilities (₹150.2B).
Long Term Liabilities: 524715's short term assets (₹393.5B) exceed its long term liabilities (₹12.2B).
Debt to Equity History and Analysis
Debt Level: 524715 has more cash than its total debt.
Reducing Debt: 524715's debt to equity ratio has reduced from 23.6% to 3.1% over the past 5 years.
Debt Coverage: 524715's debt is well covered by operating cash flow (602.5%).
Interest Coverage: 524715 earns more interest than it pays, so coverage of interest payments is not a concern.